Compare IDEXX Laboratories, Inc. (IDXX) vs IQIYI Inc - ADR (IQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs IQIYI Inc - ADR — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while IQIYI Inc - ADR trades at $1.02 (market cap $974.67M). The key difference: IDEXX Laboratories, Inc. is far larger — about 41.5× IQIYI Inc - ADR's market cap, and IDEXX Laboratories, Inc. is more actively traded (692,164 versus 4,964,108). Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and IQIYI Inc - ADR for 55 Days on average.
| IDXX | IQ | |
|---|---|---|
Market Cap | $40.43B | $974.67M |
Volume | 692,164 | 4,964,108 |
Sector | Health | Media |
52-Week High | $766.68 | $2.35 |
52-Week Low | $504.70 | $0.86 |
Typical Hold Time | 46 Days | 55 Days |
Enterprise Value | $41.32B | $2.47B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $518.00, up 2.24% with strong earnings beats in recent quarters. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and product expansions highlight growth initiatives. Analyst consensus remains bullish with a $665 price target, though technical indicators suggest near-term caution.
Outlook remains positive driven by diagnostic innovation and recurring revenue growth, but faces headwinds from FX volatility and weaker U.S. vet visits. The 36.06 P/E ratio reflects premium valuation, requiring sustained execution. Risks include competitive pressures and insider selling, while institutional ownership trends show mixed signals.
iQIYI (IQ) trades at $1.02, up 0.49% with bearish technical signals despite recent earnings beats. The company faces revenue contraction to $27.29B in 2025 and negative net margins (-3.22%), though valuation ratios like P/S (0.25) and P/B (0.52) appear attractive. Recent news highlights AI-driven content initiatives, including the successful 'The Ferry Man' series, as management pivots to offset streaming declines.
Outlook remains challenged by sustained losses and competitive pressures, but analyst consensus leans bullish (50% Buy ratings). Key risks include execution on AI content monetization and Chinese regulatory environment. The stock's deep value profile offers speculative appeal if operational turnaround materializes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About IQIYI Inc - ADR
iQIYI Inc is an online entertainment service provider in China. It is primarily engaged in providing a variety of services encompassing internet video, live broadcasting, online games, online literature, animations, e-commerce, and social media platform. The company produces original video content and distributes appealing professionally produced content, partner-generated content, and user-generated content. It also offers a diverse collection of internet video content that appeals to users from broad demographics. The company's revenue is generated from membership services and online advertising services. The company earns most of its revenue from China.
Read more on IQ →
